FDA seeks feedback on regulating generative AI-enabled medical devices in new discussion paper
emmanuelvivier · x · 2026-08-22
The FDA's Digital Health Center of Excellence has published a discussion paper, "Considerations for the Regulation of Generative AI-Enabled Medical Devices," requesting stakeholder feedback. It notes GenAI-enabled devices hold transformative promise for patient care but may introduce unique risks compared to traditional software and AI-enabled devices.
Topics covered, each with questions:
- Risk assessment considerations for GenAI-enabled devices
- Premarket evaluation approaches
- Postmarket surveillance, including agentic models
Related event: FDA Seeks Public Input on Generative AI Medical Device Regulation(2 posts)→
More from Safety
- Sam Altman on the AI dilemma: trade-offs between loss of control and power centralization — r0ck3t23 · 2026-08-24
- Debate erupts over lethal military robots vs. failing civilian units — teortaxesTex · 2026-08-24
- Only 1 of 20 Potential Presidential Candidates Answered AI Pause Query — DavidSKrueger · 2026-08-24
- Chinese Transforming Robot Dog Sparks US Trade Policy Criticism — TinfoilTricorn · 2026-08-24
- Turkey blocks at least 12 Grok posts on national security grounds — Unusual_Variation293 · 2026-08-24
- Nature Comment: Provenance, not interpretability, grounds trust in autonomous science — gabepgomes · 2026-08-24